These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32657778)

  • 1. Precision metabolome reprogramming for imprecision therapeutics in retinitis pigmentosa.
    Caruso SM; Ryu J; Quinn PM; Tsang SH
    J Clin Invest; 2020 Aug; 130(8):3971-3973. PubMed ID: 32657778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV-Txnip prolongs cone survival and vision in mouse models of retinitis pigmentosa.
    Xue Y; Wang SK; Rana P; West ER; Hong CM; Feng H; Wu DM; Cepko CL
    Elife; 2021 Apr; 10():. PubMed ID: 33847261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia modulation by TGF-β1 protects cones in mouse models of retinal degeneration.
    Wang SK; Xue Y; Cepko CL
    J Clin Invest; 2020 Aug; 130(8):4360-4369. PubMed ID: 32352930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CX3CL1 gene therapy improves cone survival and function in mouse models of retinitis pigmentosa.
    Wang SK; Xue Y; Rana P; Hong CM; Cepko CL
    Proc Natl Acad Sci U S A; 2019 May; 116(20):10140-10149. PubMed ID: 31036641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa.
    Zhang L; Chen C; Fu J; Lilley B; Berlinicke C; Hansen B; Ding D; Wang G; Wang T; Shou D; Ye Y; Mulligan T; Emmerich K; Saxena MT; Hall KR; Sharrock AV; Brandon C; Park H; Kam TI; Dawson VL; Dawson TM; Shim JS; Hanes J; Ji H; Liu JO; Qian J; Ackerley DF; Rohrer B; Zack DJ; Mumm JS
    Elife; 2021 Jun; 10():. PubMed ID: 34184634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of Cone Degeneration in Retinitis Pigmentosa.
    Song DJ; Bao XL; Fan B; Li GY
    Cell Mol Neurobiol; 2023 Apr; 43(3):1037-1048. PubMed ID: 35792991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the mechanisms of cone degeneration in retinitis pigmentosa.
    Narayan DS; Wood JP; Chidlow G; Casson RJ
    Acta Ophthalmol; 2016 Dec; 94(8):748-754. PubMed ID: 27350263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-syndromic retinitis pigmentosa.
    Verbakel SK; van Huet RAC; Boon CJF; den Hollander AI; Collin RWJ; Klaver CCW; Hoyng CB; Roepman R; Klevering BJ
    Prog Retin Eye Res; 2018 Sep; 66():157-186. PubMed ID: 29597005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term preservation of cone photoreceptors and visual acuity in rd10 mutant mice exposed to continuous environmental enrichment.
    Barone I; Novelli E; Strettoi E
    Mol Vis; 2014; 20():1545-56. PubMed ID: 25489227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of retinitis pigmentosa 2 (RP2) protein affects cone photoreceptor sensory cilium elongation in mice.
    Li L; Rao KN; Zheng-Le Y; Hurd TW; Lillo C; Khanna H
    Cytoskeleton (Hoboken); 2015 Sep; 72(9):447-54. PubMed ID: 26383048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrl knockdown by AAV-delivered CRISPR/Cas9 prevents retinal degeneration in mice.
    Yu W; Mookherjee S; Chaitankar V; Hiriyanna S; Kim JW; Brooks M; Ataeijannati Y; Sun X; Dong L; Li T; Swaroop A; Wu Z
    Nat Commun; 2017 Mar; 8():14716. PubMed ID: 28291770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RPGR-associated retinal degeneration in human X-linked RP and a murine model.
    Huang WC; Wright AF; Roman AJ; Cideciyan AV; Manson FD; Gewaily DY; Schwartz SB; Sadigh S; Limberis MP; Bell P; Wilson JM; Swaroop A; Jacobson SG
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5594-608. PubMed ID: 22807293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia Inhibition Delays Retinal Degeneration Due to MerTK Phagocytosis Receptor Deficiency.
    Lew DS; Mazzoni F; Finnemann SC
    Front Immunol; 2020; 11():1463. PubMed ID: 32765507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration.
    Gupta N; Brown KE; Milam AH
    Exp Eye Res; 2003 Apr; 76(4):463-71. PubMed ID: 12634111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical models of retinitis pigmentosa: The trophic factor hypothesis.
    Roberts PA
    J Theor Biol; 2022 Feb; 534():110938. PubMed ID: 34687673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribosomal protein S6 kinase 1 promotes the survival of photoreceptors in retinitis pigmentosa.
    Lin B; Xiong G; Yang W
    Cell Death Dis; 2018 Nov; 9(12):1141. PubMed ID: 30442943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing for a gap junction-mediated bystander effect in retinitis pigmentosa: secondary cone death is not altered by deletion of connexin36 from cones.
    Kranz K; Paquet-Durand F; Weiler R; Janssen-Bienhold U; Dedek K
    PLoS One; 2013; 8(2):e57163. PubMed ID: 23468924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of microglial activation is neuroprotective in a mouse model of human retinitis pigmentosa.
    Peng B; Xiao J; Wang K; So KF; Tipoe GL; Lin B
    J Neurosci; 2014 Jun; 34(24):8139-50. PubMed ID: 24920619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited retinal degenerations: therapeutic prospects.
    Delyfer MN; Léveillard T; Mohand-Saïd S; Hicks D; Picaud S; Sahel JA
    Biol Cell; 2004 May; 96(4):261-9. PubMed ID: 15145530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming towards anabolism impedes degeneration in a preclinical model of retinitis pigmentosa.
    Zhang L; Justus S; Xu Y; Pluchenik T; Hsu CW; Yang J; Duong JK; Lin CS; Jia Y; Bassuk AG; Mahajan VB; Tsang SH
    Hum Mol Genet; 2016 Oct; 25(19):4244-4255. PubMed ID: 27516389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.